An Open Label Study for Participants With Rheumatoid Arthritis

Clinical trial NCT01215942 · TERMINATED

Trial details

NCT number: NCT01215942
Sponsor: Eli Lilly and Company
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Rheumatoid Arthritis

Start date: 2011-06-01
Primary completion: 2014-02-01
Enrollment: 1086

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.